Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
2-[(13S,16S,19S,22S,25S,28S,31S,34S)-25-(4-aminobutyl)-19,28-bis[(2S)-butan-2-yl]-31,34-bis(carboxymethyl)-22-(hydroxymethyl)-16-[(4-hydroxyphenyl)methyl]-12,15,18,21,24,27,30,33,36-nonaoxo-2-oxa-11,14,17,20,23,26,29,32,35-nonaazatetracyclo[37.4.0.0^{3,8}.0^{4,43}]tritetraconta-1(43),3(8),4,6,39,41-hexaen-13-yl]acetic acid
ID: ALA2153731
PubChem CID: 53392941
Max Phase: Preclinical
Molecular Formula: C59H78N10O18
Molecular Weight: 1215.33
Molecule Type: Small molecule
Associated Items: